GHISELLI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 4.563
EU - Europa 2.495
AS - Asia 865
AF - Africa 115
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
OC - Oceania 2
Totale 8.047
Nazione #
US - Stati Uniti d'America 4.546
UA - Ucraina 618
IT - Italia 352
SE - Svezia 337
IE - Irlanda 328
SG - Singapore 283
DE - Germania 263
TR - Turchia 260
DK - Danimarca 234
CN - Cina 178
FI - Finlandia 135
KR - Corea 123
FR - Francia 117
CI - Costa d'Avorio 94
GB - Regno Unito 58
MA - Marocco 21
CA - Canada 16
BE - Belgio 14
RU - Federazione Russa 14
IN - India 11
NL - Olanda 11
RO - Romania 7
EU - Europa 4
PK - Pakistan 4
BG - Bulgaria 3
CL - Cile 3
IL - Israele 3
IR - Iran 3
PL - Polonia 2
AU - Australia 1
CR - Costa Rica 1
HR - Croazia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 8.047
Città #
Jacksonville 623
Chandler 568
Fairfield 442
Dublin 328
Boardman 293
Ashburn 257
Wilmington 245
Woodbridge 225
New York 188
Houston 167
Seattle 162
Ann Arbor 139
Lawrence 131
Princeton 131
San Mateo 127
Cambridge 119
Singapore 104
Abidjan 94
Des Moines 68
Turin 63
San Diego 51
Centro 49
Beijing 28
Guangzhou 18
Porto 17
Shanghai 17
Helsinki 16
Brussels 14
Norwalk 13
Ottawa 13
Izmir 12
Redmond 12
Pune 11
Wuhan 11
Falls Church 10
Fermo 10
Kilburn 10
London 10
Dallas 9
Los Angeles 9
Ancona 8
Dronten 8
Washington 8
Buffalo 7
Moscow 7
Jiaxing 6
Rome 6
Wuxi 6
Auburn Hills 5
Marche 5
Karachi 4
North Bergen 4
Palermo 4
Venice 4
Bologna 3
Breda Di Piave 3
Campobasso 3
Chiswick 3
Cingoli 3
Hounslow 3
Nanjing 3
Osimo 3
Prescot 3
San Jose 3
Shenzhen 3
Acton 2
Birmingham 2
Caserta 2
Clifton 2
Foligno 2
Fort Worth 2
Hadera 2
Heze 2
Lodz 2
Longyan 2
Meppel 2
Milan 2
Mondavio 2
Montemarciano 2
New Bedfont 2
Pergola 2
Redwood City 2
Scandicci 2
Serra 2
Simi Valley 2
Squinzano 2
Zibo 2
'Omer 1
Amandola 1
Amsterdam 1
Auckland 1
Belgrade 1
Berlin 1
Dalian 1
Drancy 1
East Los Angeles 1
Edgbaston 1
Fayetteville 1
Fuzhou 1
Hangzhou 1
Totale 4.986
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 153
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 130
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 116
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 105
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 103
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 99
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 96
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 92
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 91
Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy 91
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 90
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 85
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 82
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 82
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 81
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 80
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 79
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 78
Urinary catheters and biofilm formation 77
Is the bipolar vessel sealer device an effective tool in robotic surgery? A retrospective analysis of our experience and a meta-analysis of the literature about different robotic procedures by investigating operative data and post-operative course 77
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 76
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 76
Attività ed espressione della ossido-nitrico sintetasi nella vescica di ratti sottoposti a neuromodulazione sacrale 76
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 75
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 75
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 75
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 74
Minimally invasive approach to the adrenal gland in obese patients with Cushing’s syndrome 74
Transanal endoscopic microsurgery: indications, tips and long-term results. A single center experience 73
Anastomotic healing in a rat model of peritonitis after non-steroidal anti-inflammatory drug administration. 73
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 72
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 72
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 72
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 72
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 71
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 71
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 71
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 70
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 70
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 69
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 68
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 68
Treatment of rectal cancer by transanal endoscopic microsurgery: experience with 425 patients. 68
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 68
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 68
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 67
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 66
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 66
Increase of n-NOS and i-NOS in Rat Colon After Sacral Neuromodulation 66
Efficacy of LL-37 and Granulocyte-Colony Stimulating Factor in a Neutropenic Murine Sepsis due to Pseudomonas aeruginosa 65
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 65
Transanal endoscopic microsurgery in the treatment of large rectal adenomas. 65
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 65
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 64
Totally robotic vs 3D laparoscopic colectomy: A single centers preliminary experience 64
S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis. 64
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide 63
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 63
Treatment of Staphylococcus aureus Biofilm infection by the quorum sensing inhibitor RIP 62
The biocompatibility of dibutyryl chitin in the context of wound dressings. 62
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 62
LL-37 protects rats against lethal gram-negative sepsis. 61
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 61
Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. 61
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 61
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 61
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 60
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 60
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 60
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 60
Transanal endoscopic microsurgery as optimal option in treatment of rare rectal lesions: A single centre experience. 59
Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis. 58
Potential therapeutic role of cationic peptides in three experimental models of septic shock 58
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 58
The bovine antimicrobial peptide BMAP-28 reduces lethality due to bacterial cell wall components in mouse models of staphylococcal sepsis 57
Protective Effect of Citropin 1.1 and Tazobactam-Piperacillin Against Oxidative Damage and Lethality in Mice Models of Gram-Negative Sepsis. 57
Robotic versus laparoscopic right colectomy for cancer: short-term outcomes and influence of Body Mass Index on conversion rate. 57
Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation 57
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to multiresistant Pseudomonas aeruginosa strain 56
Nitric Oxide Synthase Expression in Rat Anorectal Tissue after Sacral Neuromodulation 56
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 55
Laparoscopic repair of giant Morgagni hernia by direct suturing with V-Loc. 55
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. 54
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 54
S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis. 54
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 54
Potential therapeutic role of histatins derivative P-113D in experimental rat models of Pseudomonas sepsis 53
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. 53
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 53
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 53
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 53
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 53
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 52
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 52
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 52
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 52
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 51
Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation 50
Efficacy of Tachyplesin III, Colistin and Imipenem against Multiresistant Pseudomonas aeruginosa 49
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 49
Totale 6.882
Categoria #
all - tutte 42.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020743 0 0 127 4 125 2 132 8 132 17 17 179
2020/20211.836 106 185 252 17 193 131 203 120 191 170 198 70
2021/20221.034 73 228 10 52 22 71 45 51 65 125 86 206
2022/20231.767 182 197 138 134 128 211 3 100 443 13 159 59
2023/2024975 175 21 59 145 168 253 17 20 5 13 14 85
2024/2025592 283 190 119 0 0 0 0 0 0 0 0 0
Totale 8.194